On March 19, a protest organized by the Diabetes Association is taking place outside the Saeima building in Latvia, demanding that the state compensates for continuous glucose monitoring sensors for type 1 diabetes patients.
On March 19, the Diabetes Association of Latvia is organizing a protest outside the Saeima building to advocate for the state to provide financial compensation for continuous glucose monitoring sensors for patients with type 1 diabetes. The protest is scheduled to take place from 8:30 AM to 11:30 AM, with organizers emphasizing the need for better support for these patients.
Despite the acknowledged clinical effectiveness of continuous glucose monitoring sensors and insulin pumps for managing type 1 diabetes within Latvia, a significant number of patients remain excluded from the state compensation system. The Diabetes Association has highlighted that the World Health Organization and international diabetes care guidelines recognize that continuous glucose monitoring systems can significantly reduce the frequency of severe hypoglycemia and improve glucose control, indicating a pressing need for government action.
Furthermore, the International Diabetes Federation has stressed that accessibility to these crucial technologies is essential not only for reducing complications associated with diabetes but also for lowering long-term health care costs. As the protest unfolds, it underscores the urgency of addressing the healthcare needs of type 1 diabetes patients and ensuring that they have access to necessary resources to manage their condition effectively.
